Jacobs Levy Equity Management’s Mesa Laboratories MLAB Stock Holding History

Jacobs Levy Equity Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13M	Buy	130,838 +86,421	+195%	+$8.7M	0.05%	281
2026 Q1	$3.93M	Buy	44,417 +5,575	+14%	+$480K	0.02%	466
2025 Q4	$3.05M	Buy	38,842 +34,985	+907%	+$2.66M	0.01%	513
2025 Q3	$258K	Buy	+3,857	New	+$278K	﹤0.01%	893
2025 Q2	–	Sell	-2,820	Closed	-$335K	–	1117
2025 Q1	$335K	Buy	+2,820	New	+$384K	﹤0.01%	965

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jacobs Levy Equity Management's MLAB Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Mesa Laboratories (MLAB) stake by 195% in Q2 2026, buying an estimated $8.7M and bringing the position to 130,838 shares worth $13M. The position accounts for 0.05% of the portfolio, ranked #281.

Jacobs Levy Equity Management first reported a position in MLAB in Q1 2025 and has held it in 5 quarters since. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Jacobs Levy Equity Management held 130,838 shares of Mesa Laboratories worth $13M as of Q2 2026.
Jacobs Levy Equity Management bought 86,421 Mesa Laboratories shares in Q2 2026, an estimated $8.7M.
Mesa Laboratories made up 0.05% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #281 holding.
Jacobs Levy Equity Management first reported a position in Mesa Laboratories in Q1 2025 and has held it in 5 quarters since.
160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.